Sino Biopharmaceutical Limited (1177.HK)
HKD 3.25
(1.25%)
HKD 3.25
(1.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.37 Billion CNY | -67.76% |
| 2022 | 4.25 Billion CNY | -23.03% |
| 2021 | 5.53 Billion CNY | -56.19% |
| 2020 | 12.62 Billion CNY | 59.33% |
| 2019 | 7.92 Billion CNY | 1463.12% |
| 2018 | 507.06 Million CNY | -77.05% |
| 2017 | 2.2 Billion CNY | 31.69% |
| 2016 | 1.67 Billion CNY | 554.74% |
| 2015 | 256.29 Million CNY | -75.13% |
| 2014 | 1.03 Billion CNY | 1470.8% |
| 2013 | -75.16 Million CNY | -569.07% |
| 2012 | 16.02 Million CNY | -42.69% |
| 2011 | 27.96 Million CNY | -74.18% |
| 2010 | 108.28 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 20.02 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | -100.0% |
| 2004 | 45.7 Million CNY | -45.04% |
| 2003 | 83.16 Million CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | 0.0% |
| 1999 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.01 Billion CNY | 0.0% |
| 2024 Q1 | 1.01 Billion CNY | -5.99% |
| 2023 Q4 | 1.37 Billion CNY | 0.0% |
| 2023 FY | 1.37 Billion CNY | -67.76% |
| 2023 Q3 | 1.37 Billion CNY | 33.11% |
| 2023 Q2 | 1.03 Billion CNY | 0.0% |
| 2023 Q1 | 1.03 Billion CNY | -75.78% |
| 2022 Q2 | 7.89 Billion CNY | 0.0% |
| 2022 Q4 | 4.25 Billion CNY | 0.0% |
| 2022 FY | 4.25 Billion CNY | -23.03% |
| 2022 Q3 | 4.25 Billion CNY | -46.09% |
| 2022 Q1 | 7.89 Billion CNY | 42.77% |
| 2021 FY | 5.53 Billion CNY | -56.19% |
| 2021 Q1 | 12.58 Billion CNY | -0.38% |
| 2021 Q2 | 11.8 Billion CNY | -6.15% |
| 2021 Q3 | 5.53 Billion CNY | -53.14% |
| 2021 Q4 | 5.53 Billion CNY | 0.0% |
| 2020 Q1 | 13.88 Billion CNY | 75.16% |
| 2020 Q2 | 14.42 Billion CNY | 3.87% |
| 2020 Q3 | 13.93 Billion CNY | -3.35% |
| 2020 Q4 | 12.62 Billion CNY | -9.39% |
| 2020 FY | 12.62 Billion CNY | 59.33% |
| 2019 Q2 | 2.46 Billion CNY | 354.93% |
| 2019 Q1 | 541.63 Million CNY | 6.82% |
| 2019 Q4 | 7.92 Billion CNY | 210.45% |
| 2019 FY | 7.92 Billion CNY | 1463.12% |
| 2019 Q3 | 2.55 Billion CNY | 3.61% |
| 2018 FY | 507.06 Million CNY | -77.05% |
| 2018 Q2 | 2.21 Billion CNY | 4.39% |
| 2018 Q1 | 2.12 Billion CNY | -4.04% |
| 2018 Q4 | 507.06 Million CNY | -6.8% |
| 2018 Q3 | 544.05 Million CNY | -75.42% |
| 2017 Q3 | 2.26 Billion CNY | 38.64% |
| 2017 Q4 | 2.2 Billion CNY | -2.36% |
| 2017 Q2 | 1.63 Billion CNY | -1.59% |
| 2017 Q1 | 1.65 Billion CNY | -1.14% |
| 2017 FY | 2.2 Billion CNY | 31.69% |
| 2016 FY | 1.67 Billion CNY | 554.74% |
| 2016 Q3 | 967.94 Million CNY | 251.16% |
| 2016 Q4 | 1.67 Billion CNY | 73.36% |
| 2016 Q1 | 272.29 Million CNY | 6.24% |
| 2016 Q2 | 275.64 Million CNY | 1.23% |
| 2015 FY | 256.29 Million CNY | -75.13% |
| 2015 Q4 | 256.29 Million CNY | -80.81% |
| 2015 Q2 | 1.3 Billion CNY | 0.42% |
| 2015 Q1 | 1.3 Billion CNY | 26.22% |
| 2015 Q3 | 1.33 Billion CNY | 2.27% |
| 2014 Q4 | 1.03 Billion CNY | 0.17% |
| 2014 Q2 | 1.03 Billion CNY | 447.99% |
| 2014 Q3 | 1.02 Billion CNY | -0.88% |
| 2014 FY | 1.03 Billion CNY | 1470.8% |
| 2014 Q1 | 189.38 Million CNY | -37.07% |
| 2013 Q4 | 300.93 Million CNY | 1789.35% |
| 2013 FY | -75.16 Million CNY | -569.07% |
| 2013 Q3 | 15.92 Million CNY | -0.87% |
| 2013 Q2 | 16.06 Million CNY | -33.12% |
| 2013 Q1 | 24.02 Million CNY | 49.92% |
| 2012 Q3 | 25.99 Million CNY | -0.13% |
| 2012 Q4 | 16.02 Million CNY | -38.36% |
| 2012 FY | 16.02 Million CNY | -42.69% |
| 2012 Q2 | 26.03 Million CNY | 0.0% |
| 2011 Q4 | 27.96 Million CNY | -68.29% |
| 2011 Q1 | 108.23 Million CNY | 0.0% |
| 2011 FY | 27.96 Million CNY | -74.18% |
| 2011 Q2 | 108.08 Million CNY | -0.14% |
| 2011 Q3 | 88.19 Million CNY | -18.4% |
| 2010 Q2 | 61.84 Million CNY | 0.0% |
| 2010 FY | 108.28 Million CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2007 FY | 20.02 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | -100.0% |
| 2004 FY | 45.7 Million CNY | -45.04% |
| 2003 FY | 83.16 Million CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 FY | - CNY | 0.0% |
| 1999 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 30.61 Million HKD | -4384.568% |
| CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 67.872% |